Markets & Stocks

Stock quotes, market indicators and the latest market news.

Market Summary Market News Stock Quotes Market Movers
Recent Quotes
My Watchlist
Indicators
Local Stocks
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Surgery Partners, Inc. - Common Stock (NQ:SGRY)

14.19 -0.37 (-2.51%)
Delayed Quote Updated: 12:44 PM EDT, Oct 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Surgery Partners, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
1 Russell 2000 Stock with Competitive Advantages and 2 Facing Headwinds
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However,... 
Via StockStory
News headline image
Surgery Partners, 10x Genomics, QuidelOrtho, Zimmer Biomet, and Tandem Diabetes Stocks Trade Down, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after sentiment in the healthcare sector weakened, as the Centers for Medicare and Medicaid S... 
Via StockStory
News headline image
Surgery Partners (SGRY): Buy, Sell, or Hold Post Q2 Earnings?
Surgery Partners’s 30.8% return over the past six months has outpaced the S&P 500 by 12.8%, and its stock price has climbed to $15.67 per share. This was par... 
Via StockStory
Topics Bankruptcy Stocks
News headline image
Surgery Partners Director Teresa DeLuca Buys 11,250 Shares ↗
As the stock price dips lower, this executive purchase shows confidence in the future of Surgery Partners. 
Via The Motley Fool
Topics Regulatory Compliance
Surgery Partners Inc (NASDAQ:SGRY) Q1 2026 Results Show Narrower Loss and Revenue Beat, But Stock Dips ↗
Via Chartmill
News headline image
3 Cash-Producing Stocks Walking a Fine Line
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff... 
Via StockStory
News headline image
Surgery Partners (SGRY) Q2 2026 Earnings Call Transcript ↗
Idaho Falls sale signals shift to pure-play surgical focus. 
Via The Motley Fool
Topics Earnings
News headline image
The Top 5 Analyst Questions From Surgery Partners’s Q2 Earnings Call
Surgery Partners’ second quarter results were received positively by the market, with management highlighting that revenue and adjusted EBITDA came in ahead ... 
Via StockStory
Topics Earnings
News headline image
1 of Wall Street’s Favorite Stocks to Research Further and 2 We Avoid
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember... 
Via StockStory
News headline image
Outpatient & Specialty Care Stocks Q2 Highlights: Surgery Partners (NASDAQ:SGRY)
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the outpatient & specialty care stocks, including Surgery Partners (NASDAQ:SGRY) and it... 
Via StockStory
Topics Artificial Intelligence
News headline image
SGRY Q2 Deep Dive: Portfolio Optimization and Acuity Mix Lead Operating Shift
Healthcare company Surgery Partners (NASDAQ:SGRY) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 2.7% year on year to $848.9 million. Th... 
Via StockStory
News headline image
Surgery Partners Q2 Earnings Call Highlights ↗
Surgery Partners (NASDAQ:SGRY) reported second-quarter 2026 revenue and adjusted EBITDA above its internal expectations, while reaffirming its full-year outlook ahead of the anticipated sale of its... 
Via MarketBeat
Topics Earnings
News headline image
Surgery Partners (NASDAQ:SGRY) Beats Q2 CY2026 Sales Expectations
Healthcare company Surgery Partners (NASDAQ:SGRY) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 2.7% year on year to $... 
Via StockStory
News headline image
Surgery Partners (SGRY) Q2 Earnings: What To Expect
Healthcare company Surgery Partners (NASDAQ:SGRY) will be announcing earnings results this Monday before market hours. Here’s what to expect. Surgery Partner... 
Via StockStory
Topics Artificial Intelligence
News headline image
1 Profitable Stock for Long-Term Investors and 2 Facing Challenges
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does... 
Via StockStory
News headline image
3 Russell 2000 Stocks We Steer Clear Of
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resou... 
Via StockStory
News headline image
1 Healthcare Stock to Target This Week and 2 We Brush Off
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as... 
Via StockStory
News headline image
3 Stocks Under $50 with Warning Signs
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha... 
Via StockStory
News headline image
1 Cash-Producing Stock Worth Your Attention and 2 We Find Risky
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff... 
Via StockStory
News headline image
Why Surgery Partners (SGRY) Stock Is Trading Up Today
What Happened? Shares of healthcare company Surgery Partners (NASDAQ:SGRY) jumped 2.7% in the morning session after Cantor Fitzgerald reiterated its "Overwei... 
Via StockStory
News headline image
Unpacking Q1 Earnings: Surgery Partners (NASDAQ:SGRY) In The Context Of Other Outpatient & Specialty Care Stocks
Looking back on outpatient & specialty care stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Surgery Partners (NASDAQ:SGRY... 
Via StockStory
Topics Artificial Intelligence
News headline image
3 Reasons to Sell SGRY and 1 Stock to Buy Instead
Surgery Partners currently trades at $15.10 per share and has shown little upside over the past six months, posting a small loss of 2.7%. The stock also fell... 
Via StockStory
News headline image
Surgery Partners vs. Viemed Healthcare: Which Outpatient Care Stock Is a Better Buy in 2026? ↗
Outpatient surgery giant or home-based respiratory care leader, which business model stands out as healthcare spending patterns evolve and margins diverge? 
Via The Motley Fool
News headline image
1 Small-Cap Stock to Keep an Eye On and 2 That Underwhelm
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and... 
Via StockStory
News headline image
3 of Wall Street’s Favorite Stocks Walking a Fine Line
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic... 
Via StockStory
Topics Economy
News headline image
5 Revealing Analyst Questions From Surgery Partners’s Q1 Earnings Call
Surgery Partners’ first quarter saw revenue growth above Wall Street expectations, with management attributing performance to stability across its surgical f... 
Via StockStory
Topics Earnings
News headline image
3 Healthcare Stocks Walking a Fine Line
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But financial performance has lagged... 
Via StockStory
News headline image
SGRY Q1 Deep Dive: Stable Margins and Physician Recruitment Offset Volume Headwinds
Healthcare company Surgery Partners (NASDAQ:SGRY) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 4.5% year on year to $8... 
Via StockStory
News headline image
Surgery Partners SGRY Q1 2026 Earnings Transcript ↗
Surgery Partners SGRY Q1 2026 Earnings Transcript 
Via The Motley Fool
News headline image
Surgery Partners’s (NASDAQ:SGRY) Q1 CY2026 Sales Beat Estimates
Healthcare company Surgery Partners (NASDAQ:SGRY) reported Q1 CY2026 results beating Wall Street’s revenue expectations, with sales up 4.5% year on year to $... 
Via StockStory
Topics Earnings
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.